Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

CSL Provides an Update on COVID-19 Vaccine

11 Dec 2020  |  07:41:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Update on UQ-CSL v451 COVID-19 Vaccine

CSL provided an update on COVID-19 vaccine. The University of Qld (UQ) and the Company announce that the Phase 1 trial of the UQ-CSL v451 COVID-19 vaccine has shown that it elicits a robust response towards the virus and has a strong safety profile. There were no serious adverse events or safety concerns reported in the 216 trial participants. However, following agreement with the Australian Government, it will not progress the vaccine candidate to Phase 2/3 clinical trials.

Please click here for full details

See more ASX300 News Announcements